Skip to main content

Jim Cramer Says Don't Get Too Excited About COVID-19 Treatment News

Publish date:
Video Rating:
Video Duration:

The World Health Organization advised doctors against using remdesivir--Gilead's antiviral drug--as a treatment for patients hospitalized with COVID-19. 

The WHO said there is currently “no evidence” that it improves survival rates or the need for ventilation in a report published in The BMJ, the British Medical Journal.

According to the report, the largest trial to date of treatments repurposed for use in the Covid-19 pandemic has shown that none of the four drugs studied produced any measurable benefit in mortality or disease course. “This includes remdesivir--a drug already recommended by several guidelines and pre-ordered by numerous governments around the world.”

Watch: Everything Jim Cramer Is Watching in Markets Friday

Latest Videos From TheStreet and Jim Cramer:

Related Videos